论文部分内容阅读
1970年12月至1983年12月收治进展期何杰金氏病38例,17例为新治,21例放疗后复发(未曾接受化疗)。男22例,女16例。中位年龄25岁。就诊时17例为Ⅱ期、12例Ⅲ期、9例Ⅳ期。化疗方案:环磷酰胺,300mg/m~2(IV),第1、8天;长春花碱10mg(IV),第1、8、15天;甲基苄肼100mg/m~2口服第1-15天;强的松40mg/m~2口服,第1-15天。休息4周再续用下一疗程,至少用6个疗程。病人获完全缓解后用化疗维持,每2-4月1次,长达3年。结果:完全缓解28例占74%,其中10例(36%)复发,完全缓解中位时间10.2年。全组病例中位生存期为8.5年。14例仍存活,12例为第1次缓解,1例为第3次缓解,1例第4次缓解。28例获完全缓解病人中位生存期为13.4年,其中17例超过10年。现仍有14例存活。复发的10例除2例外皆死亡。未获
From December 1970 to December 1983, there were 38 cases of Hodgkin’s disease, 17 cases of Neosyndrome, and 21 cases of recurrence after radiotherapy (no chemotherapy). There were 22 males and 16 females. The median age is 25 years old. At the time of treatment, 17 cases were stage II, 12 cases were stage III, and 9 cases were stage IV. Chemotherapy regimen: cyclophosphamide, 300 mg/m 2 (IV) on days 1 and 8; vinblastine 10 mg (IV) on days 1, 8 and 15; methylbenzaldehyde 100 mg/m 2 oral -15 days; prednisone 40 mg/m~2 orally, day 1-15. Take a rest for 4 weeks and continue with the next session with at least 6 sessions. The patient is treated with chemotherapy after complete remission, once every 2-4 months for up to 3 years. RESULTS: Complete remission in 28 patients accounted for 74%, of which 10 (36%) relapsed and the median time of complete remission was 10.2 years. The median survival time for the entire group was 8.5 years. 14 cases were still alive, 12 cases were the first remission, 1 case was the third remission, and 1 case was the 4th remission. The median survival of 28 patients with complete remission was 13.4 years, of which 17 cases exceeded 10 years. There are still 14 cases of survival. In 10 cases of recurrence, 2 cases died. Unaccepted